TipRanks
Go Ultimate55% OFF

Ilya M Rachman Insider Profile

4 Followers

Ilya M Rachman, CEO & Chairman, Director at Immix Biopharma, holds 1.14M shares in Immix Biopharma (Ticker: IMMX). Most recently, Ilya M Rachman Bought 746 shares of Immix Biopharma on Dec 10, 2025 for an estimated value of $4.98K.

Ilya M Rachman's Trading History

IMMX
Immix Biopharma
Dec 10, 2025CEO & Chairman, DirectorInformative Buy4.98K$8.77M
IMMX
Insider Shares: 1.14M (3.40%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 10, 2025Informative Buy$4.98K746$6.67+14.10%
Sep 17, 2025Informative Buy$5.05K2,500$2.02+548.90%
Jun 20, 2025Informative Buy$4.99K2,178$2.29+289.20%
Jun 10, 2024Informative Buy$5.54K2,600$2.13+16.40%
Jun 05, 2024Informative Buy$5.94K3,300$1.80+5.20%

You May Also Like

Ilya M Rachman insider profile FAQ

What is the percentage of profitable transactions made by Ilya M Rachman?
The percentage of profitable transactions made by Ilya M Rachman is 75%.
What is the average return per transaction made by Ilya M Rachman?
The average return per transaction made by Ilya M Rachman is 142.70%.
What stocks does Ilya M Rachman hold?
Ilya M Rachman holds: IMMX stocks.
What was Ilya M Rachman’s latest transaction?
Ilya M Rachman’s latest transaction was an Informative Buy of $4.98K.
What was Ilya M Rachman's most profitable transaction?
Ilya M Rachman’s most profitable transaction was an Informative Buy of IMMX stock on September 17, 2025. The return on the trade was 548.90%.
What is Ilya M Rachman's role in Immix Biopharma?
Ilya M Rachman's role in Immix Biopharma is CEO & Chairman, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.